The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
North Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer (NORTH/HGCSG1003).
 
Toshiaki Shichinohe
No Relationships to Disclose
 
Satoshi Yuki
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda
 
Norihiko Takahashi
No Relationships to Disclose
 
Hiroshi Nakatsumi
No Relationships to Disclose
 
Yasuyuki Kawamoto
No Relationships to Disclose
 
Takaya Kusumi
No Relationships to Disclose
 
Atsushi Ishiguro
No Relationships to Disclose
 
Susumu Sogabe
No Relationships to Disclose
 
Ichiro Iwanaga
No Relationships to Disclose
 
Kazuteru Hatanaka
No Relationships to Disclose
 
Kazuyoshi Oomori
No Relationships to Disclose
 
Michio Nakamura
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo
Research Funding - Astellas Pharma (Inst); Takeda (Inst); Zeria Pharmaceutical (Inst)
 
Naoto Senmaru
No Relationships to Disclose
 
Kazuhiro Iwai
No Relationships to Disclose
 
Masahiko Koike
No Relationships to Disclose
 
Naoya Sakamoto
No Relationships to Disclose
 
Akinobu Taketomi
Consulting or Advisory Role - Bayer
Speakers' Bureau - Astellas Pharma; Kaken Pharmaceutical; Taiho Pharmaceutical; Taisho Toyama Pharma; Takeda; Yakult Honsha
Research Funding - Asahi Kasei (Inst); Astellas Pharma (Inst); Covidien (Inst); CSL Behring (Inst); EA Pharma (Inst); Kaken Pharmaceutical (Inst); Merck Serono (Inst); Taiho Pharmaceutical (Inst); Taisho Toyama Pharma (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Satoshi Hirano
No Relationships to Disclose
 
Yoichi M Ito
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Nihon Medi-Physics (Inst)
 
Yoshito Komatsu
Speakers' Bureau - Bayer Yakuhin; Chugai Pharma; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma; EA Pharma; Taiho Pharmaceutical; Takeda